25th Nov 2022 11:37
Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Receives a deferred consideration of GBP4.0 million relating to the sale of its CD4 business.
In August, Omega sold its CD4-focused Global Health division for GBP6.1 million to Accubio Ltd, a wholly-owned subsidiary of Chinese biotechnology firm Zhejiang Orient Gene Biotech Co Ltd.
Current stock price: 4.08 pence, up 13% on Friday
12-month change: down 86%
By Abby Amoakuh; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
ODX.L